CSL’s Seqirus expects to double flu vaccine production at NC plant
Seqirus, a vaccine business owned by Australian biotech CSL, expects production of its influenza vaccine Flucelvax Quadrivalent at a North Carolina manufacturing plan...
From Depression to Deep-Learning: Leveraging iPSC and AI Platforms for Evidence-Based Depression Treatment
Continue readingAdvertisement
Advertisement
Advertisement
Advertisement
IBI – International Biopharmaceutical Industry was established to fill in the void for effective marketing and communication between all stakeholders in the Life sciences sector globally.